Press Release

According to the latest report by IMARC Group titled, “Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, The global allergy immunotherapies market was worth US$ 1.6 Billion in 2018. Allergy immunotherapies, also referred to as allergy shots, refer to treatments used for curing life-threatening allergic reactions to stinging insects. These therapies involve the repeated administration of specific allergens to a patient until their immune system modifies accordingly.  Looking forward, IMARC Group expects the market to reach a value of US$ 2.4 Billion by 2024, registering a CAGR of around 7% during 2019-2024.

Request for a free sample copy of this report:

Nowadays, the vast majority of people worldwide are suffering from different types of allergies, including contact dermatitis, allergic asthma, allergic rhinitis, and anaphylaxis. This has augmented the demand for medical treatments, such as allergy immunotherapy. Apart from this, there has been a rise in the awareness among consumers about several health benefits of allergy immunotherapy, such as enhancing microbial tolerance, improving immunological abilities, reducing inflammation and irritation, and offering long-term relief. Owing to this, a large number of patients are opting for allergy immunotherapies. Moreover, the rising research and development (R&D) activities in the healthcare sector have enabled the leading pharmaceutical firms to introduce drug for treating an array of allergies successfully. This will continue to catalyze the growth of the market in the forthcoming years.

Buy full report with table of contents:

Breakup by Treatment Type:

1. Subcutaneous Immunotherapy (SCIT)
2. Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

1. Allergic Rhinitis
2. Asthma
3. Food Allergy
4. Venom Allergy
5. Others

Breakup by Distribution Channel:

1. Hospital Pharmacy
2. Retail Pharmacy
3. Online Pharmacy

Breakup by Region:

1. Europe
2. North America
3. Asia Pacific
4. Middle East and Africa
5. Latin America

Competitive Landscape:

The report has also examined the competitive landscape of global Allergy Immunotherapies Market. Some of the major players in the market are ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.

Key highlights of the report:

1. Market Performance
2. Market Outlook
3. Porter’s Five Forces Analysis
4. Market Drivers and Success Factors
5. SWOT Analysis
6. Value Chain
7. Competitive Structure
8. Profiles of Key Players

Contact US:
309 2nd St, Brooklyn, NY 11215, USA
Email: [email protected]
USA: +1-631-791-1145, UK: +44-702-409-7331
Follow us on twitter: @imarcglobal

This post was originally published on Stock Markets News

[email protected]

IMARC Group is a leading market research company that provides market and business research intelligence across the globe. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. We make an effort to fulfill specific and niche requirements of the industry while balancing the quantum of quality with stipulated time and trace major trends at both the domestic and global levels. The information products and services provided by IMARC cover major technological, scientific and economic developments in industrial, pharmaceutical and high technology organizations.